China Resources Pharmaceutical Group Limited
CRPGF
$0.5414
$0.54140.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.33% | -6.03% | 4.52% | 6.52% | 9.90% |
| Total Depreciation and Amortization | 4.41% | 11.04% | 18.30% | 19.64% | 22.17% |
| Total Amortization of Deferred Charges | -- | -191.83% | -195.73% | -191.57% | -- |
| Total Other Non-Cash Items | 13.24% | 13.79% | 13.85% | 19.68% | 27.90% |
| Change in Net Operating Assets | 168.72% | 457.78% | 243.79% | 249.53% | 288.81% |
| Cash from Operations | 14.91% | 42.22% | 77.67% | 56.86% | 36.87% |
| Capital Expenditure | -3.36% | -5.05% | -6.29% | -7.28% | -9.15% |
| Sale of Property, Plant, and Equipment | 2.78% | 48.63% | 135.82% | 135.10% | 135.11% |
| Cash Acquisitions | -372.23% | -247.96% | -164.05% | -98.24% | 447,181.69% |
| Divestitures | -107.25% | 223.72% | 151.48% | -77.64% | -90.84% |
| Other Investing Activities | -1,079.69% | -523.95% | -233.69% | -204.20% | -138.68% |
| Cash from Investing | -334.97% | -1,197.01% | -715.19% | -7,296.91% | -144.13% |
| Total Debt Issued | -6.39% | -1.60% | 4.85% | -5.44% | -13.37% |
| Total Debt Repaid | 1.40% | -6.56% | -16.82% | 0.27% | 13.07% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -70.51% | -39.82% | -4.35% | -4.35% | -4.35% |
| Other Financing Activities | -1,088.48% | -507.97% | -136.79% | -3.99% | 65.43% |
| Cash from Financing | -370.88% | -265.84% | -155.83% | -12.82% | 62.03% |
| Foreign Exchange rate Adjustments | -452.37% | -103.81% | -99.23% | -98.06% | -72.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.07% | -147.54% | -96.95% | 19.42% | 938.49% |